Third virus vaccine reaches major hurdle: final US testing

(AP) A third leading candidate COVID-19 vaccine has entered a final stage of human testing in the United States. AstraZeneca announced Monday its potential COVID-19 vaccine has entered final trials in the U.S. to test the effectiveness and safety of the product. The Cambridge, England-based company said the trial will involve up to 30,000 adults …

The post Third virus vaccine reaches major hurdle: final US testing appeared first on 93.9 The Eagle.